Both in Pharmaceuticals
PMGC Holdings vs Artelo Biosciences
Over the past year ELAB returned −99.9% and ARTL returned −95.5%; their daily moves had a correlation of 0.20.
ELAB −99.9% ARTL −95.5%Growth of $1, one year, split-adjusted
| Metric | ELAB | ARTL |
|---|---|---|
| Price | $1.92 | $2.27 |
| Market cap | $1.6M | $1.2M |
| Today | −1.03% | −5.42% |
| 1 month | −41.3% | −34.4% |
| 6 months | −91.0% | −90.9% |
| Year to date | −99.5% | −93.1% |
| 1 year | −99.9% | −97.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | 29.5% | — |
| Net margin | −225.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.6× | — |
| Net cash | $9.4M | $4.2M |
| Dividend yield | — | — |
| Volatility (60d) | 677.7% | 650.5% |
| Short % of float | 0.4% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).